Walleye Trading
CERO

Walleye Trading’s CERo Therapeutics CERO Stock Holding History

Walleye Trading’s Portfolio CERO Stock Details CERO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13
Closed -$297K – 5482
2023
Q4 		$297K Hold
13
– – ﹤0.01% 3496
2023
Q3 		$293K Hold
13
– – ﹤0.01% 3371
2023
Q2 		$294K Hold
13
– – ﹤0.01% 3166
2023
Q1 		$288K Hold
13
– – ﹤0.01% 3245
2022
Q4 		$277K Buy
+13
New +$265K ﹤0.01% 3315

Other funds holding CERO

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
PA
Pineridge Advisors St. Charles, Missouri $350M AUM 6.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Walleye Trading's CERO Position: Q1 2024 in Review

Walleye Trading sold out of CERo Therapeutics (CERO) in Q1 2024, closing a stake of 13 shares — an estimated $297K sold.

Walleye Trading first reported a position in CERO in Q4 2022 and held it in 5 quarters. The position peaked at $297K in Q4 2023. 7 funds tracked by Wall St. Rank hold CERO as of Q1 2024.

  • Walleye Trading reported no remaining CERo Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 13 CERo Therapeutics shares in Q1 2024, an estimated $297K.
  • Walleye Trading first reported a position in CERo Therapeutics in Q4 2022 and held it in 5 quarters.
  • Walleye Trading's CERo Therapeutics position peaked at $297K in Q4 2023.
  • 7 funds tracked by Wall St. Rank held CERo Therapeutics as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.